TwinBeech Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
10,789
-84,615
| -89% | -$3.08M | 0.01% | 523 |
|
|
2025
Q1 | $3.45M | Buy |
95,404
+61,547
| +182% | +$2.23M | 0.06% | 306 |
|
|
2024
Q4 | $1.42M | Buy |
33,857
+28,497
| +532% | +$1.2M | 0.02% | 354 |
|
|
2024
Q3 | $298K | Sell |
5,360
-12,453
| -70% | -$692K | 0.01% | 617 |
|
|
2024
Q2 | $732K | Buy |
+17,813
| New | +$732K | 0.01% | 425 |
|
|
2022
Q4 | – | Sell |
-110,066
| Closed | -$4.56M | – | 894 |
|
|
2022
Q3 | $4.56M | Buy |
+110,066
| New | +$4.56M | 0.12% | 205 |
|
|
2021
Q3 | – | Sell |
-17,927
| Closed | -$1.71M | – | 724 |
|
|
2021
Q2 | $1.71M | Buy |
+17,927
| New | +$1.71M | 0.21% | 147 |
|
|
2021
Q1 | – | Sell |
-6,830
| Closed | -$945K | – | 639 |
|
|
2020
Q4 | $945K | Buy |
+6,830
| New | +$945K | 0.15% | 184 |
|